NCT04729660 is a NA clinical trial of Kinesio Tex Gold in Mutational Falsetto, sponsored by Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization.

Who is sponsoring NCT04729660?

NCT04729660 is sponsored by Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization.

What drugs are being tested in NCT04729660?

Interventions in NCT04729660: Kinesio Tex Gold.

What condition does NCT04729660 study?

NCT04729660 studies Mutational Falsetto, Dysphonia.

Is NCT04729660 still recruiting?

NCT04729660 is currently completed. Last updated 4 February 2021.

Last reviewed 2021-02-04 · How we verify

NCT04729660

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy of Kinesio Taping on Mutational Falsetto

Completed NA Last updated 4 February 2021

What this trial tests

NA trial testing Kinesio Tex Gold in Mutational Falsetto in 30 participants. Completed in 31 January 2021.

Timeline

31 July 2020

Primary endpoint
31 January 2021

31 January 2021

Quick facts

Lead sponsor	Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	30
Start date	31 July 2020
Primary completion	31 January 2021
Estimated completion	31 January 2021
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Kinesio Tex Gold

Conditions studied

Mutational Falsetto — all drugs for Mutational Falsetto →
Dysphonia — all drugs for Dysphonia →

Sponsor

Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization

Who can join

Adults 18 to 60, male only, with Mutational Falsetto or Dysphonia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to assess of efficacy of the kinesio-taping on male patients suffering from mutational falsetto

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Kinesio Tex Gold

Trials testing the same drug.

NCT04691310 — The Efficacy of Kinesio Taping on Lymphedema Following Head and Neck Cancer Therapy · NA · completed

Other Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization trials

Trials by the same sponsor.

NCT07500285 — Yittrium-90(Y-90) Fibroblast Activation Protein Inhibitor (FAPI) Therapy in Patients With Non-Small Cell Lung Cancer (Ph · Phase 2 · not yet recruiting
NCT07489794 — URINARY INCONTINENCE AND PELVIC FLOOR MUSCLE ACTIVITY IN MULTIPLE SCLEROSIS · recruiting
NCT07390279 — Efficacy of Transcutaneous Pulsed Radiofrequency in Postherpetic Neuralgia · recruiting
NCT07357922 — Serum Progesterone and Threatened Abortion During Lactation · not yet recruiting
NCT07283250 — Development and Validation of the Air Quality Awareness Scale (AQAS) for Parents · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04729660 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
Last refreshed: 4 February 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04729660.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing